share_log

Reg-Galapagos和Adaptimmune签署临床合作协议并可选择独家许可Adaptimmune的Tcr T细胞候选疗法Uza-Cell用于头颈癌和潜在的未来实体瘤适应症

Zhitong Finance ·  May 30 16:06

Reg-Galapagos和Adaptimmune签署临床合作协议并可选择独家许可Adaptimmune的Tcr T细胞候选疗法Uza-Cell用于头颈癌和潜在的未来实体瘤适应症

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment